S 1873 RS

Calendar No. 257

109th CONGRESS

1st Session

S. 1873

To prepare and strengthen the biodefenses of the United States against deliberate, accidental, and natural outbreaks of illness, and for other purposes.

IN THE SENATE OF THE UNITED STATES

October 17, 2005

Mr. BURR (for himself, Mr. ENZI, Mr. GREGG, Mr. FRIST, Mr. ALEXANDER, and Mrs. DOLE) introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions

October 24, 2005

Reported by Mr. ENZI, with an amendment

[Strike out all after the enacting clause and insert the part printed in italic]


A BILL

To prepare and strengthen the biodefenses of the United States against deliberate, accidental, and natural outbreaks of illness, and for other purposes.

[Struck out->] SECTION 1. SHORT TITLE. [<-Struck out]

[Struck out->] SEC. 2. TABLE OF CONTENTS. [<-Struck out]

[Struck out->] SEC. 3. BIOMEDICAL ADVANCED RESEARCH AND DEVELOPMENT AGENCY. [<-Struck out]

[Struck out->] `SEC. 319L. BIOMEDICAL ADVANCED RESEARCH AND DEVELOPMENT AGENCY. [<-Struck out]

[Struck out->] SEC. 4. CLARIFICATION OF COUNTERMEASURES COVERED BY PROJECT BIOSHIELD. [<-Struck out]

[Struck out->] SEC. 5. ORPHAN DRUG MARKET EXCLUSIVITY FOR COUNTERMEASURE PRODUCTS. [<-Struck out]

[Struck out->] `SEC. 505C. ORPHAN DRUG MARKET EXCLUSIVITY FOR COUNTERMEASURE PRODUCTS. [<-Struck out]

[Struck out->] SEC. 6. LIABILITY PROTECTIONS FOR PANDEMICS, EPIDEMICS, AND COUNTERMEASURES. [<-Struck out]

[Struck out->] `SEC. 319F-3. LIABILITY PROTECTIONS FOR PANDEMIC AND EPIDEMIC PRODUCTS AND SECURITY COUNTERMEASURES. [<-Struck out]

[Struck out->] SEC. 7. COMPENSATION. [<-Struck out]

[Struck out->] `PART D--OTHER COMPENSATION PROGRAMS [<-Struck out]

[Struck out->] `SEC. 271. COVERED COUNTERMEASURES PROGRAM. [<-Struck out]

[Struck out->] SEC. 8. REBATES AND GRANTS FOR RESEARCH DEVELOPMENT, AND MANUFACTURING OF VACCINES, QUALIFIED COUNTERMEASURES AND PANDEMIC OR EPIDEMIC PRODUCTS. [<-Struck out]

[Struck out->] `SEC. 319M. GRANTS TO EXPAND AND IMPROVE RESEARCH AND DEVELOPMENT AND MANUFACTURING OF VACCINES, QUALIFIED COUNTERMEASURES OR QUALIFIED PANDEMIC OR EPIDEMIC PRODUCTS. [<-Struck out]

[Struck out->] SEC. 9. TECHNICAL ASSISTANCE. [<-Struck out]

[Struck out->] `SEC. 565. TECHNICAL ASSISTANCE. [<-Struck out]

[Struck out->] SEC. 10. ANIMAL MODELS FOR CERTAIN DISEASES. [<-Struck out]

[Struck out->] `SEC. 409J. ANIMAL MODELS FOR CERTAIN DISEASES. [<-Struck out]

[Struck out->] SEC. 11. ANIMAL MODEL/RESEARCH TOOL SCIENTIFIC ADVISORY COMMITTEE. [<-Struck out]

[Struck out->] `SEC. 566. ANIMAL MODEL/RESEARCH TOOL SCIENTIFIC ADVISORY COMMITTEE. [<-Struck out]

[Struck out->] SEC. 12. COLLABORATION AND COORDINATION. [<-Struck out]

[Struck out->] SEC. 13. PROCUREMENT. [<-Struck out]

[Struck out->] `(aa) the dosing and administration requirements for countermeasures to be developed and procured; [<-Struck out]

[Struck out->] `(bb) the amount of funding that will be dedicated by the Secretary for research and development of the countermeasure; and [<-Struck out]

[Struck out->] `(cc) the specifications the countermeasure must meet to qualify for procurement under a contract under this section.'; and [<-Struck out]

[Struck out->] SEC. 14. NATIONAL PATHOLOGY CENTER. [<-Struck out]

[Struck out->] `Subpart 7--National Pathology Center [<-Struck out]

[Struck out->] `SEC. 485A. ESTABLISHMENT OF NATIONAL PATHOLOGY CENTER. [<-Struck out]

[Struck out->] `SEC. 485B. PURPOSES AND FUNCTIONS OF THE CENTER. [<-Struck out]

[Struck out->] `SEC. 485C. BOARD OF REGENTS. [<-Struck out]

[Struck out->] `SEC. 485D. GIFTS TO THE CENTER. [<-Struck out]

[Struck out->] `SEC. 485E. CENTER FACILITIES. [<-Struck out]

SECTION 1. SHORT TITLE.

SEC. 2. TABLE OF CONTENTS.

SEC. 3. BIOMEDICAL ADVANCED RESEARCH AND DEVELOPMENT AGENCY.

`SEC. 319L. BIOMEDICAL ADVANCED RESEARCH AND DEVELOPMENT AGENCY.

SEC. 4. CLARIFICATION OF COUNTERMEASURES COVERED BY PROJECT BIOSHIELD.

SEC. 5. ORPHAN DRUG MARKET EXCLUSIVITY FOR COUNTERMEASURE PRODUCTS.

`SEC. 505C. ORPHAN DRUG MARKET EXCLUSIVITY FOR COUNTERMEASURE PRODUCTS.

SEC. 6. LIABILITY PROTECTIONS FOR PANDEMICS, EPIDEMICS, AND COUNTERMEASURES.

`SEC. 319F-3. LIABILITY PROTECTIONS FOR PANDEMIC AND EPIDEMIC PRODUCTS AND SECURITY COUNTERMEASURES.

SEC. 7. COMPENSATION.

`PART D--OTHER COMPENSATION PROGRAMS

`SEC. 271. COVERED COUNTERMEASURES PROGRAM.

SEC. 8. REBATES AND GRANTS FOR RESEARCH DEVELOPMENT, AND MANUFACTURING OF VACCINES, QUALIFIED COUNTERMEASURES AND PANDEMIC OR EPIDEMIC PRODUCTS.

`SEC. 319M. GRANTS TO EXPAND AND IMPROVE RESEARCH AND DEVELOPMENT AND MANUFACTURING OF VACCINES, QUALIFIED COUNTERMEASURES OR QUALIFIED PANDEMIC OR EPIDEMIC PRODUCTS.

SEC. 9. TECHNICAL ASSISTANCE.

`SEC. 565. TECHNICAL ASSISTANCE.

SEC. 10. ANIMAL MODELS FOR CERTAIN DISEASES.

`SEC. 409J. ANIMAL MODELS FOR CERTAIN DISEASES.

SEC. 11. ANIMAL MODEL/RESEARCH TOOL SCIENTIFIC ADVISORY COMMITTEE.

`SEC. 566. ANIMAL MODEL/RESEARCH TOOL SCIENTIFIC ADVISORY COMMITTEE.

SEC. 12. COLLABORATION AND COORDINATION.

SEC. 13. PROCUREMENT.

`(aa) the dosing and administration requirements for countermeasures to be developed and procured;

`(bb) the amount of funding that will be dedicated by the Secretary for research and development of the countermeasure; and

`(cc) the specifications the countermeasure must meet to qualify for procurement under a contract under this section.'; and

SEC. 14. NATIONAL PATHOLOGY CENTER.

`Subpart 7--National Pathology Center

`SEC. 485A. ESTABLISHMENT OF NATIONAL PATHOLOGY CENTER.

`SEC. 485B. PURPOSES AND FUNCTIONS OF THE CENTER.

`SEC. 485C. BOARD OF REGENTS.

`SEC. 485D. GIFTS TO THE CENTER.

`SEC. 485E. CENTER FACILITIES.

SEC. 15. RULE OF CONSTRUCTION.

Calendar No. 257

109th CONGRESS

1st Session

S. 1873

A BILL

To prepare and strengthen the biodefenses of the United States against deliberate, accidental, and natural outbreaks of illness, and for other purposes.


October 24, 2005

Reported with an amendment

END